In 1978, Schulkin entered graduate school at the University of Pennsylvania in the Department of Philosophy on a full scholarship award and with an interest in pragmatism and the philosophy of science, but then transferred and eventually received a PhD in Behavioral Neuroscience at that same university. His work on the brain systems that underlie behavioral adaptation (e.g. appetitive and consummatory experiences) has continued to be informed by this philosophical orientation.He has received a number of awards including a MacArthur Foundation post-doctoral award through the University of Pennsylvania, a Research Career Development Award from the National Institutes of Mental Health, and a Program Project Award from the National Institute of Mental Health for work done at the University of Pennsylvania and Rockefeller University. This work was centered on the cephalic and behavioral regulation of the internal milieu. Schulkin is the author of number of papers (over 300) and books, including Roots of Social Sensibility and Neural Function and Rethinking Homeostasis (both from MIT Press), Neuroendocrine Regulation of Behavior and Cognitive Adaptation (both from Cambridge University Press), Bodily Sensibility: Intelligent Action (Oxford University Press); his most recent book is with Michael Power on the Evolution of Obesity (Johns Hopkins University Press).
Presently Schulkin is Research Professor, Department of Neuroscience at Georgetown University School of Medicine and a Research Associate, Behavioral Endocrinology Section at the National Institute of Mental Health and Director of Research, The American College of Obstetricians and Gynecologists.
Mark Lampert is the founder and president of the Biotechnology Value Fund, L.P., a San Francisco-based, private investment firm established in 1993. Mr. Lampert has engaged in ventures relating to the biotechnology industry since 1984. Mr Lampert was a Vice President at the investment banking firm Oppenheimer & Co. in New York, founded Biotechnology Royalty Corp., which pooled biotechnology patent royalties owned by universities, headed business development for Cambridge NeuroScience, and served as Assistant to the President of the NutraSweet Company, a subsidiary of G.D. Searle & Co. Mr Lampert started his career at the Boston Consulting Group. Mr Lampert is currently a director of Acumen, Inc., Biotica Technology, Ltd, and Mendel Biotechnology and a trustee of the Lampert Family Foundation. He holds an AB Degree in chemistry from Harvard College and an MBA Degree from Harvard Business School.
Former Board Chair of ClearWater Initiative, Brett currently serves as a government attorney specializing in international and national security law. A native of Swampscott, Massachusetts, Brett has worked on Capitol Hill and served as a Presidential Management Fellow in the Department of Homeland Security. Brett is a graduate of Boston University, the Fletcher School of Law and Diplomacy at Tufts University and Suffolk University Law School. he lives with his wife and daughter just outside Washington, D.C.